在全身性自身免疫性疾病中,新的和潜在的未来治疗选择
Lili Balogh1,2, Katalin Oláh1,2, Soma Sánta1,2
1Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary.
Frontiers in immunology
|April 1, 2024
概括
新的疗法为系统性自身免疫性疾病 (如狼和类风湿性关节炎) 提供了希望,当传统治疗失败时. 本综述涵盖了已批准的药物和有希望的候选药物,以改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫性炎症是由自我耐受性丧失引起的,导致器官特异性或全身性疾病.
- 系统性自身免疫性疾病越来越普遍,需要有效的慢性疾病管理.
- 许多患者对当前的合成疾病修饰性抗风湿药物和向疗法的反应不足.
研究的目的:
- 审查最近批准的用于系统性自身免疫性疾病的药物.
- 突出未来治疗选择的有前途的候选药物.
- 为系统性红斑狼,类风湿性关节炎,肖格伦病,系统性硬化,系统性血管炎和自身免疫性肌肉炎的治疗提供概述.
主要方法:
- 对已批准和正在研究的药物进行文献审查.
- 专注于针对特定系统性自身免疫性疾病的治疗方法.
- 综合有关当前和新兴治疗策略的信息.
主要成果:
- 已经批准了几种新药,并可供临床使用.
- 许多有前途的候选药物正在开发中.
- 该综述整合了关于一系列系统性自身免疫性疾病治疗方法的信息.
结论:
- 最近的进展为系统性自身免疫性疾病提供了改进的治疗途径.
- 新兴药物候选者对未来的治疗模式具有重大承诺.
- 对新的和即将到来的治疗方法的全面了解对于管理这些慢性疾病至关重要.
相关概念视频
01:29Autoimmune Disorders
430
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
430
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K